Cencora

The story of Cencora is a narrative of evolution, resilience, and a relentless commitment to global health. It began not in a boardroom, but with a single apprenticeship in 1871, when Lucien Napoleon Brunswig embarked on a journey that would lay the foundation for a pharmaceutical empire. Over the next century, this modest beginning grew through strategic partnerships and a dedication to efficiency, eventually leading to the formation of Bergen Brunswig.

In 2001, a pivotal chapter was written when Bergen Brunswig merged with AmeriSource Health Corporation to create AmerisourceBergen. This union forged a powerhouse in pharmaceutical sourcing and distribution, capable of navigating the complex logistics of delivering life-saving medications to every corner of the globe. For two decades, the company operated under this banner, expanding its reach, acquiring new capabilities in animal health and specialty services, and cementing its status as a Fortune 500 leader.

The most recent transformation occurred in 2023, when the company unified its diverse portfolio under the name Cencora. This rebrand was more than a name change; it represented a strategic alignment of its global enterprises to better serve partners and patients. Today, Cencora stands at the center of the healthcare supply chain, leveraging advanced technology and a workforce of over 46,000 to ensure that vital treatments reach those who need them most, continuing a legacy that spans more than 150 years.